Team Gleason has expanded its collaboration with Stentrode developer Synchron to help teach people about brain-computer ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback